オープンアクセス

オープンアクセスを義務付けられた論文 - Lucia Altucci, MD, PhD詳細

一般には非公開: 24 件

Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities

D Rotili, S Tomassi, M Conte, R Benedetti, M Tortorici, G Ciossani, ...

Journal of medicinal chemistry 57 (1), 42-55, 2014

委任: Fondazione Cariplo, Government of Italy

確認

Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1

H Chaib, A Nebbioso, T Prebet, R Castellano, S Garbit, A Restouin, N Vey, ...

Leukemia 26 (4), 662-674, 2012

委任: National Institute of Health and Medical Research, France

確認

HDAC inhibitors as epigenetic regulators for cancer immunotherapy

M Conte, R De Palma, L Altucci

The international journal of biochemistry & cell biology 98, 65-74, 2018

委任: European Commission, Government of Italy

確認

Indole-derived psammaplin A analogues as epigenetic modulators with multiple inhibitory activities

R Pereira, R Benedetti, S Perez-Rodriguez, A Nebbioso, ...

Journal of Medicinal Chemistry 55 (22), 9467-9491, 2012

委任: Government of Spain

確認

Epigenetic-based therapy: from single-to multi-target approaches

R Benedetti, M Conte, C Iside, L Altucci

The international journal of biochemistry & cell biology 69, 121-131, 2015

委任: Government of Italy

確認

Effects of novel SGLT2 inhibitors on cancer incidence in hyperglycemic patients: a meta-analysis of randomized clinical trials

R Benedetti, G Benincasa, K Glass, U Chianese, MT Vietri, R Congi, ...

Pharmacological Research 175, 106039, 2022

委任: Government of Italy, AIRC Foundation for Cancer Research in Italy

確認

Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia

A Nebbioso, R Benedetti, M Conte, C Iside, L Altucci

Expert Opinion on Therapeutic Targets 19 (9), 1187-1202, 2015

委任: Government of Italy

確認

Synthetic approaches to DNMT inhibitor SGI-1027 and effects on the U937 leukemia cell line

P Garcia-Dominguez, C Dell’Aversana, R Alvarez, L Altucci, AR de Lera

Bioorganic & medicinal chemistry letters 23 (6), 1631-1635, 2013

委任: Government of Spain

確認

Design, Synthesis, and Biological Evaluation of 2‐Aminobenzanilide Derivatives as Potent and Selective HDAC Inhibitors

DA Stolfa, A Stefanachi, JM Gajer, A Nebbioso, L Altucci, S Cellamare, ...

ChemMedChem 7 (7), 1256-1266, 2012

委任: German Research Foundation

確認

Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies

M Brindisi, C Cavella, S Brogi, A Nebbioso, J Senger, S Maramai, A Ciotta, ...

Future Medicinal Chemistry 8 (13), 1573-1587, 2016

委任: German Research Foundation, European Commission, Government of Italy

確認

Targeting ROS production through inhibition of NADPH oxidases

J Reis, C Gorgulla, M Massari, S Marchese, S Valente, B Noce, L Basile, ...

Nature chemical biology 19 (12), 1540-1550, 2023

委任: US National Institutes of Health, European Commission, AIRC Foundation for …

確認

Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability

S Federico, T Khan, A Fontana, S Brogi, R Benedetti, F Sarno, G Carullo, ...

European journal of medicinal chemistry 238, 114409, 2022

委任: Department of Biotechnology, India, Government of Italy, AIRC Foundation for …

確認

Total synthesis of the proposed structures of the DNA methyl transferase inhibitors peyssonenynes, and structural revision of peyssonenyne B

P García-Domínguez, I Lepore, C Erb, H Gronemeyer, L Altucci, R Álvarez, ...

Organic & Biomolecular Chemistry 9 (20), 6979-6987, 2011

委任: Government of Spain

確認

Synthesis and Biological Evaluation of Tripartin, a Putative KDM4 Natural Product Inhibitor, and 1‐Dichloromethylinden‐1‐ol Analogues

L Guillade, F Sarno, H Tarhonskaya, A Nebbioso, S Alvarez, A Kawamura, ...

ChemMedChem 13 (18), 1949-1956, 2018

委任: Cancer Research UK, UK Engineering and Physical Sciences Research Council …

確認

Secretome profiling of cytokines and growth factors reveals that neuro‐glial differentiation is associated with the down‐regulation of Chemokine Ligand 2 (MCP‐1/CCL2) in …

M Miceli, C Dell'Aversana, R Russo, C Rega, L Cupelli, M Ruvo, L Altucci, ...

Proteomics 16 (4), 674-688, 2016

委任: Government of Italy

確認

Glycation of wild‐type apomyoglobin induces formation of highly cytotoxic oligomeric species

C Iannuzzi, V Carafa, L Altucci, G Irace, M Borriello, R Vinciguerra, ...

Journal of Cellular Physiology 230 (11), 2807-2820, 2015

委任: Government of Italy

確認

A key HDAC6 dependency of ARID1A-mutated ovarian cancer

L Altucci

Nature Cell Biology 19 (8), 889-890, 2017